These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 16570231)
1. Immunohistochemical analysis of human skeletal muscle AMP deaminase deficiency. Evidence of a correlation between the muscle HPRG content and the level of the residual AMP deaminase activity. Sabbatini AR; Toscano A; Aguennouz M; Martini D; Polizzi E; Ranieri-Raggi M; Moir AJ; Migliorato A; Musumeci O; Vita G; Raggi A J Muscle Res Cell Motil; 2006; 27(1):83-92. PubMed ID: 16570231 [TBL] [Abstract][Full Text] [Related]
2. Role of the HPRG Component of Striated Muscle AMP Deaminase in the Stability and Cellular Behaviour of the Enzyme. Ronca F; Raggi A Biomolecules; 2018 Aug; 8(3):. PubMed ID: 30142952 [TBL] [Abstract][Full Text] [Related]
3. Presence in human skeletal muscle of an AMP deaminase-associated protein that reacts with an antibody to human plasma histidine-proline-rich glycoprotein. Sabbatini AR; Ranieri-Raggi M; Pollina L; Viacava P; Ashby JR; Moir AJ; Raggi A J Histochem Cytochem; 1999 Feb; 47(2):255-60. PubMed ID: 9889261 [TBL] [Abstract][Full Text] [Related]
4. The role of histidine-proline-rich glycoprotein as zinc chaperone for skeletal muscle AMP deaminase. Ranieri-Raggi M; Moir AJ; Raggi A Biomolecules; 2014 May; 4(2):474-97. PubMed ID: 24970226 [TBL] [Abstract][Full Text] [Related]
5. Association of purified skeletal-muscle AMP deaminase with a histidine-proline-rich-glycoprotein-like molecule. Ranieri-Raggi M; Montali U; Ronca F; Sabbatini A; Brown PE; Moir AJ; Raggi A Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):641-8. PubMed ID: 9307011 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the zinc-binding site of the histidine-proline-rich glycoprotein associated with rabbit skeletal muscle AMP deaminase. Mangani S; Meyer-Klaucke W; Moir AJ; Ranieri-Raggi M; Martini D; Raggi A J Biol Chem; 2003 Jan; 278(5):3176-84. PubMed ID: 12441349 [TBL] [Abstract][Full Text] [Related]
7. AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects. Fischer H; Esbjörnsson M; Sabina RL; Strömberg A; Peyrard-Janvid M; Norman B J Appl Physiol (1985); 2007 Jul; 103(1):315-22. PubMed ID: 17463303 [TBL] [Abstract][Full Text] [Related]
8. Isolation by zinc-affinity chromatography of the histidine-proline-rich-glycoprotein molecule associated with rabbit skeletal muscle AMP deaminase. Evidence that the formation of a protein-protein complex between the catalytic subunit and the novel component is critical for the stability of the enzyme. Ranieri-Raggi M; Martini D; Sabbatini AR; Moir AJ; Raggi A Biochim Biophys Acta; 2003 Jan; 1645(1):81-8. PubMed ID: 12535614 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the metallocenter of rabbit skeletal muscle AMP deaminase. Evidence for a dinuclear zinc site. Mangani S; Benvenuti M; Moir AJ; Ranieri-Raggi M; Martini D; Sabbatini AR; Raggi A Biochim Biophys Acta; 2007 Feb; 1774(2):312-22. PubMed ID: 17254852 [TBL] [Abstract][Full Text] [Related]
10. AMP deaminase deficiency in skeletal muscle is unlikely to be of clinical relevance. Hanisch F; Joshi P; Zierz S J Neurol; 2008 Mar; 255(3):318-22. PubMed ID: 18338202 [TBL] [Abstract][Full Text] [Related]
16. Molecular basis of AMP deaminase deficiency in skeletal muscle. Morisaki T; Gross M; Morisaki H; Pongratz D; Zöllner N; Holmes EW Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6457-61. PubMed ID: 1631143 [TBL] [Abstract][Full Text] [Related]
17. Evidence that muscle cells do not express the histidine-rich glycoprotein associated with AMP deaminase but can internalise the plasma protein. Sabbatini AR; Mattii L; Battolla B; Polizzi E; Martini D; Ranieri-Raggi M; Moir AJ; Raggi A Eur J Histochem; 2011 Feb; 55(1):e6. PubMed ID: 21556121 [TBL] [Abstract][Full Text] [Related]
18. AMP deaminase deficiency: study of the human skeletal muscle purine metabolism during ischaemic isometric exercise. Sinkeler SP; Binkhorst RA; Joosten EM; Wevers RA; Coerwinkei MM; Oei TL Clin Sci (Lond); 1987 Apr; 72(4):475-82. PubMed ID: 3829596 [TBL] [Abstract][Full Text] [Related]
19. Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle. Sabina RL; Swain JL; Olanow CW; Bradley WG; Fishbein WN; DiMauro S; Holmes EW J Clin Invest; 1984 Mar; 73(3):720-30. PubMed ID: 6707201 [TBL] [Abstract][Full Text] [Related]
20. Effect of AMP-deaminase 3 knock-out in mice on enzyme activity in heart and other organs. Rybakowska I; Romaszko P; Zabielska M; Turyn J; Kaletha K; Barton PJ; Slominska EM; Smolenski RT Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):319-22. PubMed ID: 24940686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]